カテゴリ： MarketLine, オーストラリア, 企業調査

Virgin Australia Holdings Ltd：企業の戦略・SWOT・財務分析

◆英語タイトル：Virgin Australia Holdings Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3798
◆発行会社（調査会社）：MarketLine
◆発行日：2019年12月
◆ページ数：55
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：オーストラリア
◆産業分野：Leisure and Arts
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Virgin Australia Holdings Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Virgin Australia Holdings Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Virgin Australia Holdings Ltd (Virgin Australia), is a provider of airline services. The company provides passenger and cargo transportation solution in domestic and international markets across Asia, North America, Europe, the Middle East and Africa. Virgin Australia operates a fleet of Boeing 777 and Boeing 737 aircraft, Airbus A320 and A330 aircraft, Fokker F100 aircraft and ATR aircraft. The company also offers fly-in fly-out charter service. Apart from these, Virgin Australia offers several other ancillary services such as holiday packages, hotel bookings, travel insurance, cruise booking, airport transfers, airport parking and car rental services. The company has alliances with Etihad Airways P.J.S.C, Delta Air Lines Inc., Alitalia, Hawaiian Airlines, South African Airways, Singapore Airlines Limited and other Virgin Group companies. Virgin Australia is headquartered in Bowen Hills, Australia.

Scope

- Detailed information on Virgin Australia Holdings Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Virgin Australia Holdings Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Virgin Australia Holdings Ltd including a breakdown and examination of key business segments
- Intelligence on Virgin Australia Holdings Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Virgin Australia Holdings Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Virgin Australia Holdings Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Virgin Australia Holdings Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Virgin Australia Holdings Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Virgin Australia Holdings Ltd: Company Overview
Virgin Australia Holdings Ltd: Overview and Key Facts
Virgin Australia Holdings Ltd: Overview
Virgin Australia Holdings Ltd: Key Facts
Virgin Australia Holdings Ltd: Key Employees
Virgin Australia Holdings Ltd: Key Employee Biographies
Virgin Australia Holdings Ltd: Major Products and Services
Virgin Australia Holdings Ltd: Company History
Virgin Australia Holdings Ltd: Management Statement
Virgin Australia Holdings Ltd: Locations and Subsidiaries
Virgin Australia Holdings Ltd: Key Competitors
Virgin Australia Holdings Ltd: Company Analysis
Virgin Australia Holdings Ltd: Business Description
Virgin Australia Holdings Ltd: SWOT Analysis
Virgin Australia Holdings Ltd: SWOT Overview
Virgin Australia Holdings Ltd: Strengths
Virgin Australia Holdings Ltd: Weaknesses
Virgin Australia Holdings Ltd: Opportunities
Virgin Australia Holdings Ltd: Threats
Virgin Australia Holdings Ltd: Corporate Financial Deals Activity
Virgin Australia Holdings Ltd: Financial Deals Overview
Virgin Australia Holdings Ltd: Targets and Partners
Virgin Australia Holdings Ltd: Top Deals 2015 – 2019YTD*
Virgin Australia Holdings Ltd: Advisors
Virgin Australia Holdings Ltd: Top Legal Advisors
Virgin Australia Holdings Ltd: Top Financial Advisors
Virgin Australia Holdings Ltd: Mergers and Acquisitions
Virgin Australia Holdings Ltd: Capital Raising
Virgin Australia Holdings Ltd: Partnership
Virgin Australia Holdings Ltd: Recent Developments
Virgin Australia Holdings Ltd: News and Events Summary
Virgin Australia Holdings Ltd: Business Expansion
Virgin Australia Holdings Ltd: Contracts
Virgin Australia Holdings Ltd: Corporate Governance
Virgin Australia Holdings Ltd: Regulatory and Legal Events
Virgin Australia Holdings Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Virgin Australia Holdings Ltd: Key Facts
Table 2: Virgin Australia Holdings Ltd: Key Employees
Table 3: Virgin Australia Holdings Ltd: Company History
Table 4: Virgin Australia Holdings Ltd: Locations and Subsidiaries
Table 5: Virgin Australia Holdings Ltd: Key Competitors
Table 6: Virgin Australia Holdings Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Virgin Australia Holdings Ltd: M&A Activity by Geography (TTM*)
Table 8: Virgin Australia Holdings Ltd: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 9: Virgin Australia Holdings Ltd: M&A Average Deal Size - Value (US$m)
Table 10: Virgin Australia Holdings Ltd: Targets and Partners
Table 11: Virgin Australia Holdings Ltd: Top Deals 2015 - 2019YTD*
Table 12: Virgin Australia Holdings Ltd: Legal Advisor Ranking by Value (US$m)
Table 13: Virgin Australia Holdings Ltd: Financial Advisor Ranking by Value (US$m)
Table 14: Virgin Australia Holdings Ltd: M&A Volume and Value Trend (2015 - YTD*2019)
Table 15: Virgin Australia Holdings Ltd: M&A Activity by Geography (2015 - YTD*2019)
Table 16: Virgin Australia Holdings Ltd: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 17: Virgin Australia Holdings Ltd: Capital Raising by Deal Type (2015 - YTD*2019)
Table 18: Virgin Australia Holdings Ltd: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 19: Virgin Australia Holdings Ltd: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 20: Virgin Australia Holdings Ltd: News and Events Summary
Table 21: Virgin Australia Holdings Ltd: Business Expansion
Table 22: Virgin Australia Holdings Ltd: Contracts
Table 23: Virgin Australia Holdings Ltd: Corporate Governance
Table 24: Virgin Australia Holdings Ltd: Regulatory and Legal Events
Table 25: Virgin Australia Holdings Ltd: Strategy and Operations

★海外企業調査レポート[Virgin Australia Holdings Ltd：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Bank Saint Petersburg：企業の戦略・SWOT・財務情報
    Bank Saint Petersburg - Strategy, SWOT and Corporate Finance Report Summary Bank Saint Petersburg - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AnaMar AB-製薬・医療分野：企業M&A・提携分析
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows poten …
  • Cerus Corp (CERS)：製薬・医療：M&Aディール及び事業提携情報
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • BioLineRx Ltd (BLRX)：企業の財務・戦略的SWOT分析
    BioLineRx Ltd (BLRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Genoptix Inc-製薬・医療分野：企業M&A・提携分析
    Summary Genoptix Inc (Genoptix) is a healthcare services provider that offers diagnostic solutions. The center offers oncology diagnostics and informatics services. It provides biopharma and healthcare laboratory, discovery, drug development, care and cost development; diagnostics, and patient servi …
  • Agenus Inc (AGEN)：企業の財務・戦略的SWOT分析
    Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Taisho Pharmaceutical Holdings Co Ltd：企業の戦略・SWOT・財務情報
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Shinhan Bank：企業のM&A・事業提携・投資動向
    Shinhan Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shinhan Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Lear Corp (LEA)：企業の財務・戦略的SWOT分析
    Lear Corp (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Circassia Pharmaceuticals Plc (CIR)-医療機器分野：企業M&A・提携分析
    Summary Circassia Pharmaceuticals plc (Circassia) develops treatments for allergy and respiratory diseases such as asthma. The company’s product line includes NIOX, which is used to improve asthma management by assisting in diagnosis. In addition, the company's pipeline includes a number of inhaled …
  • GulfMark Offshore Inc (GLF)：石油・ガス：M&Aディール及び事業提携情報
    Summary GulfMark Offshore Inc (GulfMark Offshore), formerly New GulfMark Offshore Inc is an oil and gas company that offers oil and gas, and marine transportation services. The company owns, operates, and manages fleet of vessels offering marine specialty services to offshore oil and natural gas dri …
  • InfraReDx Inc-医療機器分野：企業M&A・提携分析
    Summary Infraredx Inc (Infraredx), a subsidiary of Nipro Corp is a medical device company that provides cardiovascular imaging solutions. The company offers TVC imaging system, a dual-modality intravascular imaging system that assesses plaque composition and vessel structure. Its TVC imaging system …
  • 1-800-FLOWERS.COM, Inc.：企業の戦略・SWOT・財務分析
    1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report Summary 1-800-FLOWERS.COM, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Xvivo Perfusion AB (XVIVO)：企業の財務・戦略的SWOT分析
    Summary Xvivo Perfusion AB (Xvivo) is a medical technology company that provides organ transplantation solutions. The company develops organ preservation products such as perfadex and silicone tubing sets and normothermic perfusion products. It offers normothermic perfusion products such as STEEN so …
  • Vyome Biosciences Pvt Ltd-製薬・医療分野：企業M&A・提携分析
    Summary Vyome Biosciences Pvt Ltd (Vyome) is a research center that develops drugs for antibiotics-resistant acne and other opportunist pathogens. The center’s platforms modify active agents based on genomic information of the disease causing micro organism. Its pro-drug platform develops therapeuti …
  • Global Blood Therapeutics Inc (GBT)：企業の財務・戦略的SWOT分析
    Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment o …
  • Oric Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Oric Pharmaceuticals Inc (Oric Pharmaceuticals) is an independent oncology company that focuses to discover and develop drugs for overcoming resistance in cancer. Its lead drug candidate ORIC-101, which is in phase 1 clinical trial, is a small molecule inhibitor of the glucocorticoid recepto …
  • Kane Biotech Inc (KNE)-医療機器分野：企業M&A・提携分析
    Summary Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develop …
  • Cunard Line：企業の戦略・SWOT・財務分析
    Cunard Line - Strategy, SWOT and Corporate Finance Report Summary Cunard Line - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Clover Corp Ltd (CLV)：企業の財務・戦略的SWOT分析
    Summary Clover Corporation Limited (Clover), is a developer of science-based bioactives. The company offers products such as DHA oils, DHA powders and microencapsulation. It delivers bioactive ingredients through encapsulation. Clover’s refined tuna oil is used in various formulations, supplements, …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆